about
First evidence of subclinical renal tubular injury during sickle-cell crisis.The prevalence of hypertension and abnormal kidney function in children with sickle cell disease -a cross sectional reviewGenetic variants and cell-free hemoglobin processing in sickle cell nephropathy.The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trialNew insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy.Biomarkers in sickle cell disease.Neutrophil gelatinase associated lipocalin in acute kidney injury.Sickle cell disease: renal manifestations and mechanismsHemoglobin inhibits albumin uptake by proximal tubule cells: implications for sickle cell disease.Predictors of renal function progression in adults with homozygous sickle cell disease.Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected womenAlbuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia.High serum N-acetyl-ß-d-glucosaminidase activity is a predictor of 28-year mortality in a population of community-dwelling Japanese-the Tanushimaru study.Cystatin C, Beta2 Microglobulin, N-Acetyl-beta-D-glucosaminidase, Retinol-Binding Protein, and Endothelin 1 Levels in the Evaluation of Sickle Cell Disease Nephropathy.Nephrin as a biomarker of sickle cell glomerulopathy in Malawi.Long-Term Endothelin-A Receptor Antagonism Provides Robust Renal Protection in Humanized Sickle Cell Disease Mice.Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis.Renal protection by atorvastatin in a murine model of sickle cell nephropathy.Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1).Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.Urinary early kidney injury molecules in children with beta-thalassemia major
P2860
Q33553300-8630A165-A116-4720-B9C4-E7D4EB0D83E9Q34509369-A85F5E3B-0A9A-46D6-AFFB-DB927C0E2F68Q36115647-75E388A2-09C3-451D-B8AF-AAEBA14F9584Q36868391-EA2032C8-095D-4900-8E3F-464BF59C2988Q37928968-29F6A829-0598-4B33-9994-77E7A452B97CQ37961814-B5C4414E-3AB1-4216-BC6E-C391EB704753Q38160639-F008E1FC-FC86-4DB0-9363-80336DA44660Q38350669-8AE4078B-6B99-47AC-B3E1-3A7ADAB2D5CBQ38709717-B066EBD8-6F23-4E61-9BA1-96E83B5A6195Q38882051-E3272F94-09B9-41C2-A55E-62F378AC62A3Q40837133-7D6F0249-0B3E-4B8E-8538-214B7D00E0DBQ42215011-D3F6E82A-B912-4785-990E-4C819257B78DQ45333207-B266180B-E8FB-4C36-A51E-8DB7E0FEF8C1Q47675922-ED61A182-CB4A-4976-919D-026C3F30DC3FQ48090226-73B51623-E187-4A2A-B19A-E1F7A11F3270Q50667811-EEF2DB09-EE7D-4EC8-ADB2-65341EBCE967Q52653120-D7D565F8-6A2A-4B26-854F-DEC5468D7D10Q52727244-C5CC4C0B-348B-400C-9CD2-1319CBA2155FQ53396943-E2E7B120-BF26-43DC-AA08-9C5BAAC9ED31Q55427971-9EC90A44-AFF2-4974-89DC-7A9680201400Q57593508-62CCAD09-07A1-49F6-A5A6-4958104BF70A
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biomarkers for early detection of sickle nephropathy
@ast
Biomarkers for early detection of sickle nephropathy
@en
Biomarkers for early detection of sickle nephropathy
@nl
type
label
Biomarkers for early detection of sickle nephropathy
@ast
Biomarkers for early detection of sickle nephropathy
@en
Biomarkers for early detection of sickle nephropathy
@nl
prefLabel
Biomarkers for early detection of sickle nephropathy
@ast
Biomarkers for early detection of sickle nephropathy
@en
Biomarkers for early detection of sickle nephropathy
@nl
P2093
P2860
P356
P1476
Biomarkers for early detection of sickle nephropathy
@en
P2093
George Atweh
Jamie Wilhelm
Michael Bennett
Nambirajan Sundaram
Punam Malik
P2860
P304
P356
10.1002/AJH.22045
P577
2011-05-31T00:00:00Z